ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,804, issued on Jan. 20, was assigned to Quicksilver Scientific Inc. (Louisville, Colo.).
"Microemulsion delivery systems for alcohol-soluble species including DHEA, pregnenolone, and chrysin for reducing menopausal symptoms" was invented by Christopher W. Shade (Louisville, Colo.) and Steven Tieu (Louisville, Colo.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Microemulsions are described where hydrophobic liquid droplets are distributed in a continuous hydrophilic liquid phase. In relation to conventional oil-in-water (OIW) microemulsions, the described microemulsions may be thought of as modified oil-in-water (MOIW) microemulsions, where both the...